Daily FNArena News - Australia

The Pommy love affair with Aussie wine appears to be over. When there’s so much of the stuff in the bargain bin, it can only be deemed to be on the nose. Foster’s should be very concerned.

Atlantic salmon sales in Australia have taken off, and Merrill Lynch is suggesting investors should get on board the healthy revolution.

Resource Capital Research forecasts a steadily climbing spot price for uranium, but not every man and his dog will automatically benefit from this.

Most securities analysts seem to be happy with the proposed tie-in between OneSteel and Smorgon, but not Credit Suisse.

Although the next CPI figure will likely be a doozy, CommBank does not believe the fundamentals justify another Australian interest rate hike.

Blame Pacifica. Blame Ion. Fact is investors are not giving management at CMI any credit, says ABN Amro.

Positive news flow over the coming year should help close the gap between the share price of ChemGenex and ABN Amro Morgans’ calculated value, the broker believes.

An interest rate rise is on the cards, TD Securities says, but argues that a reactive move in August is the most likely outcome.

The shares are considered a long term buy as profits are expected to soar over the next years. FY09 net profit is estimated at $93.5m.

CommSec and JP Morgan join the growing list of brokers calling for a return to upside, albeit with a little less of the euphoria we’ve enjoyed in recent times.